Drug Type Small molecule drug |
Synonyms JNJ-26146900 |
Target |
Action antagonists |
Mechanism AR antagonists(Androgen Receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC15H15F3N2O3S |
InChIKeyUJGGNFGSHPHGNE-AWEZNQCLSA-N |
CAS Registry868691-50-3 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Prostatic Cancer | Discovery | United States | - |





